Insulin detemir is associated with more predictable glycemic control and lower risk of hypoglycemia compared to NPH insulin in subjects with type 1 diabetes

被引：0
|
作者：
Vague, P
Selam, JL
Skeie, S
De Leeuw, I
Willem, J
Elte, F
Haahr, H
Kristensen, A
Draeger, E
机构：
来源：
DIABETES | 2002年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
473
引用
收藏
页码：A116 / A117
页数：2
相关论文
共 50 条
  • [31] Switching to insulin detemir improves glycemic control and significantly reduces hypoglycemia over 52 weeks in french subjects with type 1 diabetes
    Hanaire, Helene
    Marre, Michel
    Laroche, Sylvie
    Ackermann, Ralf W.
    [J]. DIABETES, 2008, 57 : A591 - A592
  • [32] Superior glycaemic control with insulin detemir compared with NPH
    Heller, Simon
    Pedersen, Claus B.
    Larsen, Jens
    [J]. DIABETES, 2007, 56 : A537 - A537
  • [33] Maternal glycaemic control and hypoglycaemia in pregnancy: a randomised trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes
    Mathiesen, E. R.
    Damm, P.
    Hod, M.
    McCance, D. R.
    Ivanisevic, M.
    Garcia, S.
    Jovanovic, L.
    [J]. DIABETOLOGIA, 2011, 54 : S486 - S487
  • [34] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
    Heise, T
    Nosek, L
    Ronn, BB
    Endahl, L
    Heinemann, L
    Kapitza, C
    Draeger, E
    [J]. DIABETES, 2004, 53 (06) : 1614 - 1620
  • [35] Insulin degludec is associated with less frequent and milder hypoglycemia in insulin-deficient patients with type 1 diabetes compared with insulin glargine or detemir
    Iwasaki S.
    Kozawa J.
    Kimura T.
    Fukui K.
    Iwahashi H.
    Imagawa A.
    Shimomura I.
    [J]. Diabetology International, 2017, 8 (2) : 228 - 236
  • [36] Perinatal outcomes in pregnancy: a randomised trial comparing insulin detemir with NPH insulin in 310 subjects with type 1 diabetes
    Hod, M.
    McCance, D. R.
    Ivanisevic, M.
    Garcia, S.
    Jovanovic, L.
    Mathiesen, E. R.
    Damm, P.
    [J]. DIABETOLOGIA, 2011, 54 : S487 - S487
  • [37] Lower risk of nocturnal hypoglycemia with insulin detemir versus NPH insulin in people with diabetes: A meta-analysis of controlled phase III trials
    Heller, S
    Olsen, KJ
    Draeger, E
    [J]. DIABETES, 2004, 53 : A487 - A487
  • [38] Insulin detemir offers improved glycemic control, less weight gain, and flexible timing of administration compared to NPH insulin
    Home, P
    Bartley, P
    Landin-Olsson, M
    Russell-Jones, D
    Hylleberg, B
    Draeger, E
    [J]. DIABETES, 2003, 52 : A122 - A122
  • [39] Risk of breast cancer in women initiating insulin glargine compared with insulin detemir Or NPH insulin
    Bradley, Marie C.
    Chillarige, Yoganand
    Lee, Hana
    Wu, Xiyuan
    Bright, Patricia
    Parulekar, Shruti
    Wernecke, Michael
    Soukup, Mat
    Kelman, Jeffrey A.
    Graham, David J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 146 - 146
  • [40] Insulin detemir provides superior glycaemic control than insulin NPH or insulin glargine in type 1 diabetic subjects in a clinical setting
    Jendle, Johan H.
    Norberg, Bengt
    [J]. DIABETES, 2007, 56 : A548 - A548
12345